子宫动脉化疗栓塞治疗子宫切口妊娠的临床观察  

Uterine artery embolization in treatment of cesarean scar prengnancy

作　　者：江恩利[1] 王萍玲[1] 吴蓓[1] 

机构地区：[1]贵州省人民医院妇产科,贵阳550002

出　　处：《中国实用医药》2013年第30期31-32,共2页China Practical Medicine

摘　　要：目的 探讨子宫动脉化疗栓塞在治疗子宫切口妊娠的临床效果.方法 回顾分析2010年1月～2012年12月收治的32例子宫切口妊娠行子宫动脉化疗栓塞治疗的病例资料.结果 32例子宫动脉化疗栓塞操作均成功.阴道大出血或不规则出血均得到有效控制.人绒毛膜促性腺激素β亚型较术前下降,差异有统计学意义（Z=-8.231,P=0.000）,术后2～15 d行B超监测下清宫术,术中失血3～90 ml,平均25ml.1例行子宫切除术,子宫切除率3％.结论 子宫动脉化疗栓塞治疗子宫切口妊娠可减少阴道流血量、降低清宫风险、减少子宫切除可能,是治疗子宫切口妊娠的有效可行方法之一.Objective To explore the clinical effect of uterine artery chemoembolization （UACE）in the treatment for the cesarean scar pregnancy（CSP）. Methods We retrospectively analyzed the clinical data of 32 patients with CSP treated by UACE in our hospital from January 2010 to February 2012. Results 32 cases of uterine arterial chemoembolization operations were successfully performed with vaginal bleeding and irregular bleeding under effective control The level of beta human ehorionic gonadotrophin was significantly decreased compared with that before the operation （Z=-8.231, P=0.000）. Curettage of uterus was carried out within 2 to 15 days after the UACE. The blood loss during curettage procedure was 3~90 ml, averaging 25 ml. One patient underwent hysterectomy, and the hysterectomy rate was 3%. Conclusion Uterine artery ehemoembolization is an effective and useful method for decreasing vaginal bleeding, diminishing the risk of curettage and avoiding the loss of uterus for patients with cesarean sear pregnancy.

关 键 词：子宫切口妊娠 子宫动脉化疗栓塞术 清宫术 甲氨蝶呤 

分 类 号：R719.8[医药卫生—妇产科学]